Children's Hospital Of Philadelphia
Clinical trials sponsored by Children's Hospital Of Philadelphia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Mini muscle sensor could unlock mitochondrial disease diagnosis Results expected Sep 2026 (estimated)
- New stem cell method aims to cut transplant risks for blood cancer patients Results expected Oct 2026 (estimated)
- New combo aims to supercharge standard thyroid cancer therapy Results expected Oct 2026 (estimated)
- Sleep more, lower blood pressure: new study for kids Results expected Nov 2026 (estimated)
- New stem cell approach could fix immune systems in kids Results expected Nov 2026 (estimated)
-
A new dosing strategy aims to hit the busulfan sweet spot in kids
Disease control Not yet recruitingThis pilot study tests whether scaling the first busulfan dose to body surface area helps children reach a therapeutic drug level after the first dose. Children up to age 21 who are scheduled for a stem cell transplant will receive busulfan either by body surface area or by an in…
Phase 1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Blood test may replace painful scopes for kids with EoE
Diagnosis Not yet recruitingThis study tests a new blood test that aims to identify which foods are triggering Eosinophilic Esophagitis (EoE) in children. About 50 kids with EoE will follow a diet based on the test results, and doctors will check if the test accurately predicts food allergies compared to st…
Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC